Midcap Stocks Research: Subscribe for 1 Year... Get Access for 3 Years
Here is the latest financial fact sheet of CONCORD BIOTECH. For more details, see the CONCORD BIOTECH quarterly results and CONCORD BIOTECH share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.5 |
No. of shares | m | 104.62 |
1 Week | % | -8.9 |
1 Month | % | -0.9 |
1 Year | % | - |
52 week H/L | Rs | 1,712.0/900.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
CONCORD BIOTECH EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | NA | |
Low | Rs | NA | NA | NA | NA | NA | |
Sales per share (Unadj.) | Rs | 458.5 | 538.7 | 648.7 | 749.7 | 81.5 | |
Earnings per share (Unadj.) | Rs | 124.5 | 177.7 | 247.0 | 183.9 | 22.9 | |
Diluted earnings per share | Rs | 11.3 | 16.2 | 22.5 | 16.7 | 22.9 | |
Cash flow per share (Unadj.) | Rs | 144.8 | 200.0 | 275.9 | 236.6 | 28.1 | |
Dividends per share (Unadj.) | Rs | 3.10 | 0.60 | 7.42 | 5.12 | 6.83 | |
Adj. dividends per share | Rs | 0.28 | 0.05 | 0.67 | 0.47 | 6.83 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 717.7 | 809.9 | 1,050.9 | 1,160.1 | 123.3 | |
Adj. book value per share | Rs | 65.2 | 73.6 | 95.5 | 105.5 | 123.3 | |
Shares outstanding (eoy) | m | 9.51 | 9.51 | 9.51 | 9.51 | 104.62 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0 | 0 | |
Avg P/E ratio | x | 0 | 0 | 0 | 0 | 0 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | 0 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | 0 | |
Dividend payout | % | 2.5 | 0.3 | 3.0 | 2.8 | 29.8 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total wages/salary | Rs m | 481 | 574 | 695 | 957 | 1,103 |
CONCORD BIOTECH INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,360 | 5,123 | 6,169 | 7,129 | 8,532 | |
Other income | Rs m | 174 | 314 | 138 | 234 | 353 | |
Total revenues | Rs m | 4,535 | 5,437 | 6,308 | 7,363 | 8,885 | |
Gross profit | Rs m | 1,807 | 2,045 | 3,275 | 2,703 | 3,505 | |
Depreciation | Rs m | 193 | 212 | 275 | 501 | 540 | |
Interest | Rs m | 9 | 12 | 10 | 61 | 98 | |
Profit before tax | Rs m | 1,779 | 2,135 | 3,127 | 2,375 | 3,220 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 595 | 445 | 778 | 626 | 819 | |
Profit after tax | Rs m | 1,184 | 1,690 | 2,349 | 1,749 | 2,401 | |
Gross profit margin | % | 41.4 | 39.9 | 53.1 | 37.9 | 41.1 | |
Effective tax rate | % | 33.5 | 20.9 | 24.9 | 26.4 | 25.4 | |
Net profit margin | % | 27.2 | 33.0 | 38.1 | 24.5 | 28.1 |
CONCORD BIOTECH BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 5,000 | 5,386 | 6,071 | 6,327 | 7,277 | |
Current liabilities | Rs m | 542 | 2,233 | 2,359 | 3,442 | 3,764 | |
Net working cap to sales | % | 102.2 | 61.5 | 60.2 | 40.5 | 41.2 | |
Current ratio | x | 9.2 | 2.4 | 2.6 | 1.8 | 1.9 | |
Inventory Days | Days | 201 | 233 | 167 | 151 | 146 | |
Debtors Days | Days | 1,328 | 1,307 | 105 | 119 | 117 | |
Net fixed assets | Rs m | 2,597 | 5,101 | 7,056 | 8,692 | 9,708 | |
Share capital | Rs m | 95 | 95 | 95 | 95 | 105 | |
"Free" reserves | Rs m | 6,730 | 7,607 | 9,899 | 10,937 | 12,795 | |
Net worth | Rs m | 6,825 | 7,702 | 9,994 | 11,032 | 12,900 | |
Long term debt | Rs m | 0 | 355 | 563 | 312 | 62 | |
Total assets | Rs m | 7,597 | 10,487 | 13,127 | 15,019 | 16,985 | |
Interest coverage | x | 192.1 | 183.9 | 299.7 | 39.7 | 33.9 | |
Debt to equity ratio | x | 0 | 0 | 0.1 | 0 | 0 | |
Sales to assets ratio | x | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | |
Return on assets | % | 15.7 | 16.2 | 18.0 | 12.1 | 14.7 | |
Return on equity | % | 17.3 | 21.9 | 23.5 | 15.9 | 18.6 | |
Return on capital | % | 26.2 | 26.6 | 29.7 | 21.5 | 25.6 | |
Exports to sales | % | 43.0 | 48.9 | 58.5 | 46.9 | 48.8 | |
Imports to sales | % | 24.0 | 24.3 | 17.3 | 14.5 | 3.5 | |
Exports (fob) | Rs m | 1,876 | 2,508 | 3,608 | 3,345 | 4,164 | |
Imports (cif) | Rs m | 1,046 | 1,245 | 1,065 | 1,034 | 298 | |
Fx inflow | Rs m | 1,876 | 2,508 | 3,608 | 3,345 | 4,164 | |
Fx outflow | Rs m | 1,046 | 1,245 | 1,065 | 1,034 | 298 | |
Net fx | Rs m | 829 | 1,262 | 2,543 | 2,312 | 3,866 |
CONCORD BIOTECH CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,629 | 1,548 | 1,668 | 2,075 | 2,460 | |
From Investments | Rs m | -1,163 | -1,127 | -1,952 | -1,118 | -1,579 | |
From Financial Activity | Rs m | -445 | -434 | 311 | -1,002 | -852 | |
Net Cashflow | Rs m | 21 | -14 | 27 | -45 | 28 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Sudhir Vaid | COMP SEC: Prakash Sajnani | YEAR OF INC: 1984 | BSE CODE: 543960 | FV (Rs): 1 | DIV YIELD (%): 0.5 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare CONCORD BIOTECH With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.